Results 31 to 40 of about 11,580 (206)
BackgroundEarly surgical closure is warranted to prevent aortic valve lesion and aortic regurgitation (AR) in intracristal ventricular septal defects (icVSDs). Experiences for transcatheter device closure of icVSDs are still limited.
Qiuman Li +5 more
doaj +1 more source
Outcomes of Patent Foramen Ovale Transcatheter Closure
El riesgo de erosión de un dispositivo de cierre septal auricular, en particular el oclusor septal Amplatzer, se ha descrito como mayor en pacientes con un borde aórtico corto. Se ha aplicado una preocupación similar a los dispositivos de cierre del foramen oval permeable (PFO), pero solo se han reportado casos raros de erosión. Puede ser que se elijan
Ada C. Stefanescu Schmidt +9 more
openaire +2 more sources
Due to the complex pathophysiology of aortic valve disease (AVD) and the resulting lack of effective pharmacotherapy, existing animal models are valuable research tools, but each has its own strengths and limitations. This review systematically surveys the major AVD models, compares their induction methods, pathological features, advantages and ...
Liya Hou +4 more
wiley +1 more source
Background: Post myocardial infarction ventricular septal rupture (MI-VSR) is a devastating complication after acute myocardial infarction (AMI); lacks uniform treatment recommendations and carries poor outcomes.
Pramod Sagar +7 more
doaj +1 more source
Transcatheter Closure of Left Ventricular Outflow Tract–to–Left Atrium Fistula
Surgical and rarely transcatheter aortic valve replacement can be complicated by intracardiac fistula. Transcatheter closure of those shunts has been previously reported with favorable results.
Yasser Sammour, MD +5 more
doaj +1 more source
The challenges of bioprosthetic heart valves (BHV) with respect to calcification, infection, and poor durability are tackled by surface engineering of hyperbranched poly‐L‐lysine (HBPL), providing a translational solution to improve long‐term valve performance.
Pai Peng +7 more
wiley +1 more source
Interventional Closure of Patent Foramen Ovale (PFO) with Amplatzer PFO Occluder in Patients with Paradoxical Cerebral Embolism [PDF]
Background: Percutaneous transcatheter closure has been proposed as an alternative to surgical closure or long-term anticoagulation in patients with presumed paradoxical embolism and patent foramen ovale (PFO).
Ali Mohammad Haji Zeinali +1 more
doaj +2 more sources
Transcatheter closure of perimembranous and muscular ventricular septal defect (VSD) has been performed widely and it has more advantages compare to surgery.
Mulyadi M Djer +3 more
doaj +2 more sources
Background: Currently, transcatheter closure of perimembranous ventricular septal defect (pmVSD) is a widely accepted therapeutic modality. However, arrhythmias, especially postprocedural heart blocks, are a concern and outcomes are not very clear.
Li-Jian Zhao +5 more
doaj +1 more source
ABSTRACT Background Transcatheter closure (TCC) of sinus venosus defects (SVD) using balloon‐expandable covered stents is an emerging alternative to surgery. ZephyrCS (Sahajanand Laser Technologies, Gandhinagar, India) is available in long lengths to suit SVD closure.
Pramod Sagar +3 more
wiley +1 more source

